Real world effectiveness of oral semaglutide: Focus on patients with type 2 diabetes older than 75 years
{{output}}
Aim: Data on the efficacy of oral semaglutide (OS) in elderly patients with type 2 diabetes are still lacking. This study evaluates the effectiveness of OS in a real world setting with a large ≥75 year old population. ... ...
